Global SCENESSE® demand drives increased CLINUVEL revenues, earnings 2023 Announcements . Financial . Regulatory 24.02.2023
Afamelanotide Significantly Reduces UV Skin Damage in a Healthy Population – Technical Note 2023 Announcements . Clinical 02.02.2023
CLINUVEL Drug Significantly Reduces Critical UV Skin Damage in Fair-Skinned Individuals 2023 Announcements . Clinical 02.02.2023
Afamelanotide Significantly Reduces UV Skin Damage in a Healthy Population 2023 Announcements . Clinical . Regulatory 02.02.2023
Technical Note: Developing a melanocortin pipeline 2023 Announcements . Corporate . Regulatory 27.01.2023